Auna SA

Auna SA(AUNA)股票分析

$5.160

+0.133 (+2.58%)收盘时

Loading chart…
最高
5.270
开盘
5.070
成交量加权均价
5.17
成交量
271.74K
市值
—
最低
5.070
成交额
1.40M
企业价值/息税折旧摊销前利润(TTM)
4.04

Auna SA is a Luxembourg-based healthcare company. The Company has a patient- centric model providing prepaid healthcare plans, medical care, and oncology solutions, that promotes integrated healthcare system, healthy lifestyles through prevention, research, and education. It offers a wide-ranging practice and prospects that enables to deliver standard services and the possible patient outcomes. Its network includes nearly 31 healthcare network facilities, consisting of regional network of hospitals, clinics, outpatient, and wellness facilities with a total of 2,308 beds. It is also located in Mexico, Peru, and Colombia.

AI 分析 of Auna SA (AUNA)

持有

Auna SA is currently not a strong buy due to mixed financial indicators and market sentiment. The current price is $5.16, with an RSI of 43.38 indicating potential weakness. Although there was a 9% year-over-year revenue growth reported, the adjusted EBITDA declined by 9% and the net income for Q2 2026 was only $6.5 million, showing volatility in profitability. The main risk is the recent downgrade by analysts, which reflects concerns over the company's financial performance and future earnings potential.

估值指标

Auna SA(AUNA)当前预期市盈率为 0.00,5 年平均预期市盈率为 9.07。

预期市盈率

严重低估
5 年均值 P/E
9.07
当前P/E
0.00
高估
11.35
低估
6.78

预期 EV/EBITDA

低估
5 年均值 EV/EBITDA
5.03
当前EV/EBITDA
4.04
高估
5.64
低估
4.43

预期市销率

低估
5 年均值 P/S
0.30
当前P/S
0.07
高估
0.47
低估
0.13

事件时间线

2026-10-22 (ET)

08:30:00

Company Expects Full-Year 2026 Revenue Growth in Line with Guidance

2026-10-21 (ET)

09:00:00

Auna Begins Construction Under PPP Agreement with EsSalud

2026-10-15 (ET)

09:00:00

Healthcare Services Company Reports Preliminary Q3 Data

2026-04-17 (ET)

08:50:00

Healthcare Services Peru Reports 4,855 Surgeries

2026-03-11 (ET)

12:00:00

Dow Jones Drops Over 400 Points Amid Oil Price Volatility

资讯

AUNA 常见问题 —— 由 Alphio AI 解答

Auna SA is a Luxembourg-based healthcare company. The Company has a patient- centric model providing prepaid healthcare plans, medical care, and oncology solutions, that promotes integrated healthcare system, healthy lifestyles through prevention, research, and education. It offers a wide-ranging practice and prospects that enables to deliver standard services and the possible patient outcomes. Its network includes nearly 31 healthcare network facilities, consisting of regional network of hospitals, clinics, outpatient, and wellness facilities with a total of 2,308 beds. It is also located in Mexico, Peru, and Colombia. It operates in the Healthcare sector.

Auna SA is currently not a strong buy due to mixed financial indicators and market sentiment. The current price is $5.16, with an RSI of 43.38 indicating potential weakness. Although there was a 9% year-over-year revenue growth reported, the adjusted EBITDA declined by 9% and the net income for Q2 2026 was only $6.5 million, showing volatility in profitability. The main risk is the recent downgrade by analysts, which reflects concerns over the company's financial performance and future earnings potential.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易